. . ", it is not a downer. >> although on the technologies we saw yesterday reported by the journal 660% of the ipos here have been tech-related which is not a reflection of a great deal of excitement. >> well, i bridle at that, because i think that biotech should be considered tech, and b biotech is the hottest year i can remember. a lot of the biotech companies came public and found people suspicious" . .